LivaNova Plc(NASDAQ) LIVN

Market Cap$4.34B

Since IPO (1993)+552%

5 Year-4%

1 Year+49%

1 Month+1%

Premium Feature

Moneyball Superscore

61/100

$78.72

+0.65%

+0.51Today

After hours$78.70-$0.02 (-0.03%)

LivaNova Plc last closing stock price
Metric	Price	Date
Last close	USD 78.74	2026-08-21

LivaNova Plc stock price return by period
Period	Price return	Price at period start	Period start date
1 week	-4.23%	USD 82.22	2026-08-14
1 month	+0.6%	USD 78.27	2026-07-22
3 month	+6.65%	USD 73.83	2026-05-22
Year to date	+27.97%	USD 61.53	2025-12-31
1 year	+48.96%	USD 52.86	2025-08-21
3 year	+42.39%	USD 55.30	2023-08-22
5 year	-4.01%	USD 82.03	2021-08-20
Since inception	+551.75%	USD 12.00	1993-02-11

LivaNova Plc Financials at a Glance

Market Cap

$4.34B

Revenue (TTM)

$1.47B

Net Income (TTM)

$188.58M

EPS (TTM)

$3.37

P/E Ratio

23.36

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$78.72

Volume

440,215.623

Open

$78.80

Price

$78.72

Volume

440,215.623

Open

$78.80

Previous Close

$78.74

Daily Range

$77.94 - $79.56

52-Week Range

$48.82 - $85.76

Estimated Earnings Date

Nov 4, 2026

Dividend

$0.00

Beta (Volatility)

0.95 (Low)

Price

$78.72

Volume

440,215.623

Open

$78.80

Previous Close

$78.74

Daily Range

$77.94 - $79.56

52-Week Range

$48.82 - $85.76

Estimated Earnings Date

Nov 4, 2026

LIVN News

LIVN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About LivaNova Plc

LivaNova PLC helps patients with heart and brain conditions. Its products support surgeons during complex heart procedures. It also treats epilepsy using nerve stimulation.

What's in the Medical Kit?

Cardiopulmonary Systems: Equipment for heart surgery like oxygenators and heart-lung machines; net revenue was $430.2 million for the six months ended June 30, 2026.
Neuromodulation Devices: Systems that stimulate the vagus nerve to treat drug-resistant epilepsy and difficult-to-treat depression; net revenue was $318.7 million for the six months ended June 30, 2026.
Obstructive Sleep Apnea Solutions: Neurostimulation devices designed to keep airways open during sleep by activating specific tongue muscles.
Advanced Circulatory Support: Technology that provides temporary life support for the heart or lungs.

Growth and New Clearances

Received FDA Premarket Approval for the aura6000 System to treat obstructive sleep apnea on March 18, 2026.
Launched the Essenz Perfusion System, a next-generation heart-lung machine with advanced patient monitoring tools.
Secured a favorable tax ruling in Italy in May 2026 regarding environmental liability deductions.
Collaborated with Verily to research clinical biomarkers for patients suffering from depression.

What Sets LivaNova Apart

LivaNova operates a global distribution network that combines direct sales teams with independent distributors. The company integrates sensing technology into its hardware to enable data-driven clinical decisions during surgeries.

Key Financial Figures

Net revenue reached $752.8 million for the six months ended June 30, 2026, up 12.5% year over year.
Net income was $130.9 million for the six months ended June 30, 2026, compared to a net loss of $300.2 million in the prior year period.
Market capitalization grew to $4.5 billion by the second quarter of 2026, up 84.1% year over year.
Research and development expense rose to $112.4 million for the six months ended June 30, 2026.
The price-to-earnings ratio was 10.4 in the second quarter of 2026, down 53.9% year over year.

Bottom Line

LivaNova has transitioned its focus toward high-tech neuromodulation and advanced cardiopulmonary systems. Its commitment to specialized medical technology supports its role in modern clinical environments.

AI Generated • Aug 6, 2026

Industry

Healthcare Equipment and Supplies

Sector

Health Care

Employees

3,300

CEO

Vladimir A. Makatsaria, MBA

Website

www.livanova.com

Headquarters

Gloucester, GL GL3 4FE, GB

LIVN Financials

Key Financial Metrics (TTM)

Gross Margin

68.18%

Operating Margin

13.48%

Net Income Margin

12.82%

Return on Equity

15.41%

Return on Capital

11.92%

Return on Assets

7.14%

Earnings Yield

4.28%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$4.34B

Shares Outstanding

55.09M

Volume

440.22K

Avg. Volume

708.19K

Financials (TTM)

Gross Profit

$1.00B

Operating Income

$198.30M

EBITDA

$180.71M

Operating Cash Flow

$249.26M

Capital Expenditure

-$100.92M

Free Cash Flow

$148.34M

Cash & ST Invst.

$516.62M

Total Debt

$351.95M

LivaNova Plc Performance Analysis

LivaNova Plc annual revenue and year-over-year revenue growth by fiscal year
Fiscal year	Period end	Revenue	YoY growth
2022	2022-12-31	USD 1,021,805,000	-1.3%
2023	2023-12-31	USD 1,153,545,000	12.9%
2024	2024-12-31	USD 1,253,437,000	8.7%
2025	2025-12-31	USD 1,388,053,000	10.7%

LivaNova Plc sequential (quarter-over-quarter) revenue growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	1.5%
Q4	2025-12-31	0.9%
Q1	2026-03-31	0.4%
Q2	2026-06-30	7.8%

LivaNova Plc annual diluted earnings per share and year-over-year EPS growth by fiscal year
Fiscal year	Period end	Diluted EPS	YoY growth
2022	2022-12-31	USD -1.61	-39.9%
2023	2023-12-31	USD 0.32	N/A
2024	2024-12-31	USD 1.16	258.0%
2025	2025-12-31	USD -4.45	N/A

LivaNova Plc sequential (quarter-over-quarter) diluted earnings per share growth by fiscal quarter
Fiscal quarter	Period end	QoQ growth
Q3	2025-09-30	-2.0%
Q4	2025-12-31	16.3%
Q1	2026-03-31	-29.8%
Q2	2026-06-30	382.5%

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name

Q2 2026YOY CHG

Revenue

$390.60M

+10.8%

Gross Profit

$273.70M

+14.5%

Gross Margin

70.07%

N/A

Market Cap

$4.34B

N/A

Market Cap/Employee

$1.31M

N/A

Employees

3,300

N/A

Net Income

$108.60M

+299.8%

EBITDA

$25.70M

-57.6%

Quarterly Fundamentals

Name

Q2 2026YOY CHG

Total Cash

$516.62M

-13.0%

Total Debt

$351.95M

-27.1%

Accounts Receivable

$274.17M

+8.4%

Inventory

$172.61M

+4.4%

Long Term Debt

$339.58M

-13.2%

Short Term Debt

$12.37M

-86.5%

Return on Assets

7.14%

N/A

Return on Invested Capital

10.25%

N/A

Free Cash Flow

$35.04M

-26.7%

Operating Cash Flow

$66.59M

+5.8%

Other Investments to Explore

People Also Watch

SymbolSymbol / CompanyCompanyPricePrice Chg

HTFLHeartflow, Inc. Common Stock

HTFLHeartflow, Inc. Common Stock$49.75+6.30%

LEGNLegend Biotech Corporation

LEGNLegend Biotech Corporation$21.82+2.63%

IDYAIDEAYA Biosciences, Inc.

IDYAIDEAYA Biosciences, Inc.$39.67+1.43%

IRONDisc Medicine, Inc.

IRONDisc Medicine, Inc.$79.81+1.23%

CDTXCidara Therapeutics, Inc.

CDTXCidara Therapeutics, Inc.$221.38+0.00%

ZLABZai Lab Limited

ZLABZai Lab Limited$26.01-0.04%

PBHPrestige Consumer Healthcare Inc.

PBHPrestige Consumer Healthcare Inc.$51.31+1.56%

Trending Stocks

SymbolSymbol / CompanyCompanyPricePrice Chg

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF

TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x ETF$9.77+0.10%

IBITiShares Bitcoin Trust

IBITiShares Bitcoin Trust$43.68+0.06%

BITOProShares Trust - ProShares Bitcoin ETF

BITOProShares Trust - ProShares Bitcoin ETF$10.41+0.06%

MARAMara Holdings

MARAMara Holdings$11.26+0.01%

NVDANvidia

NVDANvidia$214.72-0.01%

INTCIntel

INTCIntel$90.07-0.02%

MRNAModerna

MRNAModerna$145.13+0.09%

Questions About LIVN

What is the current price of LivaNova Plc?

LivaNova Plc is trading at $78.74 per share.

What is the 52-week range for LivaNova Plc?

Over the past 52 weeks, LivaNova Plc has traded between $48.82 and $85.76.

How much debt does LivaNova Plc have?

As of the most recent reporting period, LivaNova Plc reported total debt of $351.95M.

How much cash does LivaNova Plc have on hand?

LivaNova Plc reported $516.62M in cash and cash equivalents in its most recent financial results.

What is LivaNova Plc’s dividend yield?

LivaNova Plc does not currently have a dividend yield.

LivaNova Plc(NASDAQ) LIVN

LivaNova Plc Financials at a Glance

LIVN News

Why Duluth Holdings, LivaNova, and Boston Beer Slumped Today

Here's Why LivaNova Plummeted Today

Why L Brands, Devon Energy, and LivaNova Slumped Today

Here's Why LivaNova Dropped Today

Here's Why LivaNova Rose as Much as 13% Today

LIVN: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

About LivaNova Plc

What's in the Medical Kit?

Growth and New Clearances

What Sets LivaNova Apart

Key Financial Figures

Bottom Line

LIVN Financials

Key Financial Metrics (TTM)

Stock Overview

Financials (TTM)

LivaNova Plc Performance Analysis

Revenue Growth Rate

Earnings Per Share Growth Rate

Quarterly Performance

Quarterly Fundamentals

Other Investments to Explore

People Also Watch

Trending Stocks

Questions About LIVN

What is the current price of LivaNova Plc?

What is the 52-week range for LivaNova Plc?

How much debt does LivaNova Plc have?

How much cash does LivaNova Plc have on hand?

What is LivaNova Plc’s dividend yield?

Premium Investing Services